Inari Medical (NARI)
(Real Time Quote from BATS)
$55.31 USD
+0.41 (0.75%)
Updated Jul 22, 2024 02:46 PM ET
3-Hold of 5 3
D Value F Growth B Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
NARI 55.31 +0.41(0.75%)
Will NARI be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for NARI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NARI
Intuitive Surgical (ISRG) Hits All-Time High: Will It Go Higher?
What's in Store for West Pharmaceutical (WST) in Q2 Earnings?
NARI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why You Should Retain Inari Medical (NARI) for Now
Veracyte (VCYT) Up 8.4% Since Last Earnings Report: Can It Continue?
Inari's (NARI) Expanding Product Portfolio Offsets Competition
Other News for NARI
Med-tech and healthcare stocks with upside during 2Q earnings - Baird
Insider Sale: Chief Medical Officer Thomas Tu Sells Shares of Inari Medical Inc (NARI)
Director William Hoffman Sells 60,000 Shares of Inari Medical Inc (NARI)
Inari Medical just downgraded at Needham, here's why
Needham cuts Inari to hold, cites competitive concerns